Title : Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.

Pub. Date : 2010 Jul

PMID : 20571072






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib, a multikinase inhibitor that targets BRaf kinase, is Food and Drug Administration approved for use in advanced renal cell and hepatocellular carcinomas. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens